NCT06167356Recruiting
Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK.
Observational Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent Endoscopic Resection Surgery for Bladder Cancer (TURBK).
Source: ClinicalTrials.gov · Last updated 12 Dec 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
A database has been created and will be used in which data will be collected in electronic format relating to adult patients who underwent one of the following endoscopic resection surgeries: TURBK, MAPPING, TURBK SECOND LOOK, BLADDER BIOPSIES.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 20000 (estimated)
- First submitted
- 12 Oct 2023
- Start date
- 27 Nov 2013
- Primary completion date
- 27 Nov 2063
- Lead sponsor
- IRCCS San Raffaele
- Diseases
- Bladder cancer
- NCT number
- NCT06167356
What you commit to
- Study type: Observational
- Planned participants: 20000
- From 27 Nov 2013 to the primary completion date, 27 Nov 2063
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Age \<18 years
Other
- Inability to read and sign the informed consent
Who the study is looking for
- 18 years or older
- Patients with non-muscle invasive bladder cancer
- Indication to cancer removal through endoscopic resection surgery
- Ability to read and sign the informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| IRCCS Ospedale San Raffaele Coordinator of this site? Confirm its status | Milan | Italy | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.